To view the PDF file, sign up for a MySharenet subscription.

APN - Aspen Pharmacare Holdings - Further announcement regarding the acquisition

Release Date: 23/11/2010 08:33
Code(s): APN
Wrap Text

APN - Aspen Pharmacare Holdings - Further announcement regarding the acquisition of The Pharmaceutical Business of Sigma Pharmaceticals Limited by Aspen ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN ISIN: ZAE000066692 ("Aspen") FURTHER ANNOUNCEMENT REGARDING THE ACQUISITION OF THE PHARMACEUTICAL BUSINESS OF SIGMA PHARMACETICALS LIMITED ("SIGMA") BY ASPEN Aspen shareholders are referred to the announcement released on the Securities Exchange News Service of the JSE Limited on 16 August 2010 wherein Aspen announced that the Aspen Group had agreed in principle to acquire the pharmaceutical business conducted by Sigma on a debt-free basis for a cash consideration of A$900 million (approximately ZAR 6 228 million at current exchange rates) ("the Transaction"). Aspen has now reached formal agreement with Sigma on the terms and conditions of the Transaction and the ongoing relationship between the two companies. The Transaction is subject to a number of conditions precedent, including Sigma Shareholder, Sigma Lender and Australian Regulatory approval. It is anticipated that Sigma will hold an Extraordinary General Meeting for the purposes of Sigma`s Shareholders considering the Transaction in mid-January 2011. Subject to satisfaction of the conditions precedent, the Transaction is scheduled to conclude on 31 January 2011. Woodmead 23 November 2010 Investment Bank and Sponsor to Aspen Investec Bank Limited (Registration number 1969/004763/06) and Investec Bank (Australia) Limited Date: 23/11/2010 08:33:21 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story